A Study of CriPec® Docetaxel Given to Patients With Solid Tumours

NCT02442531 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Metastatic Cancer
Solid Tumors

Interventions

DRUG: CriPec® docetaxel

Sponsor

Cristal Therapeutics